Shares of Agilon Health, Inc. (NYSE:AGL – Get Free Report) have earned an average rating of “Hold” from the eighteen ratings firms that are currently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, eleven have issued a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $4.79.
A number of research firms recently issued reports on AGL. The Goldman Sachs Group lifted their price objective on Agilon Health from $2.50 to $5.00 and gave the company a “neutral” rating in a research report on Thursday, May 8th. Royal Bank Of Canada lifted their price target on Agilon Health from $3.00 to $3.50 and gave the company an “outperform” rating in a report on Wednesday, February 26th. TD Cowen boosted their price target on Agilon Health from $3.50 to $6.00 and gave the company a “hold” rating in a research note on Tuesday, April 15th. Sanford C. Bernstein upgraded Agilon Health from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $3.30 to $8.50 in a report on Tuesday, April 8th. Finally, Citigroup upgraded shares of Agilon Health from a “neutral” rating to a “buy” rating and lifted their target price for the company from $3.25 to $5.00 in a research note on Friday, April 25th.
Check Out Our Latest Research Report on Agilon Health
Institutional Trading of Agilon Health
Agilon Health Stock Performance
Agilon Health stock opened at $2.12 on Wednesday. The firm has a market cap of $875.50 million, a PE ratio of -3.58 and a beta of 0.14. The firm’s 50 day moving average price is $3.23 and its two-hundred day moving average price is $3.21. Agilon Health has a twelve month low of $1.50 and a twelve month high of $7.73.
Agilon Health (NYSE:AGL – Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.04. Agilon Health had a negative net margin of 4.04% and a negative return on equity of 45.47%. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.50 billion. During the same quarter last year, the business posted ($0.02) EPS. The company’s revenue for the quarter was down 4.5% on a year-over-year basis. Equities analysts anticipate that Agilon Health will post -0.59 EPS for the current fiscal year.
Agilon Health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Recommended Stories
- Five stocks we like better than Agilon Health
- What is the Dogs of the Dow Strategy? Overview and Examples
- Analyst Downgrades Joby, But Overlooks Major Regulatory Wins
- Top Stocks Investing in 5G Technology
- U.S. Steel Stock Burns the Bears With Surprise Upside Move
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Lululemon, UNH, Enphase: Bad News, Good Opportunity?
Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.